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Nicotine dependence is linked to single nucleotide
polymorphisms in the CHRNB4-CHRNA3-CHRNA5
gene cluster encoding the a3b4a5 nicotinic acetyl-
choline receptor (nAChR). Here we show that the
b4 subunit is rate limiting for receptor activity, and
that current increase by b4 is maximally competed
by one of the most frequent variants associated
with tobacco usage (D398N in a5). We identify a b4-
specific residue (S435), mapping to the intracellular
vestibule of the a3b4a5 receptor in close proximity
to a5 D398N, that is essential for its ability to increase
currents. Transgenic mice with targeted overexpres-
sion of Chrnb4 to endogenous sites display a strong
aversion to nicotine that can be reversed by viral-
mediated expression of the a5 D398N variant in
the medial habenula (MHb). Thus, this study both
provides insights into a3b4a5 receptor-mediated
mechanisms contributing to nicotine consumption,
and identifies the MHb as a critical element in the
circuitry controlling nicotine-dependent phenotypes.
INTRODUCTION
Tobacco use is a major public health challenge that leads to
millions of preventable deaths every year (http://www.who.int/
tobacco/statistics/tobacco_atlas/en/). The principal addictive
component of tobacco is the plant alkaloid nicotine, which
binds and activates nicotinic acetylcholine receptors (nAChRs)
(Dani and Heinemann, 1996). In the mammalian nervous
system, eight alpha (a2–a7 and a9–a10) and three beta (b2–b4)
subunits assemble into pentameric nAChR combinations with
distinctive pharmacological and functional properties (Gotti
et al., 2009; McGehee and Role, 1995). Recently, genome-wide
association studies (GWAs) have identified genetic variants in522 Neuron 70, 522–535, May 12, 2011 ª2011 Elsevier Inc.the CHRNB4/A3/A5 gene cluster as risk factors for nicotine
dependence and lung cancer (Amos et al., 2010a; Saccone
et al., 2009; Thorgeirsson et al., 2008; Weiss et al., 2008). These
single nucleotide polymorphisms (SNPs) include noncoding vari-
ants across the gene cluster, as well as amino acid substitutions
(http://www.ncbi.nlm.nih.gov/snp/). Given that cis-regulatory
elements within the cluster coordinate transcription of these
genes for assembly of a3b4-containing (a3b4*) and a3b4a5
functional nAChRs (Scofield et al., 2010; Xu et al., 2006), the
fact that a large number of SNPs map to noncoding segments
of the cluster suggests that altered regulation of these genes
can contribute to the pathophysiology of tobacco use. Indeed
the risk for nicotine dependence seems to stem from at least
two separate mechanisms: the variability in the mRNA levels of
these genes and functional changes due to nonsynonymous
amino acid variants (Lu et al., 2009).
A number of mouse models with gene deletions, point muta-
tions, or strain-specific variants in nAChR subunits have been
critical to elucidate the role of the different nAChR combinations
in nicotine addiction and withdrawal. For instance, a4b2
nAChRs, accounting for 80% of the high-affinity nicotine binding
sites in the brain (Whiting and Lindstrom, 1988), are major
contributors to nicotine self-administration, as shown in b2
knockout (KO) mice (Maskos et al., 2005; Picciotto, 1998) and
in knockin mice with a gain-of-function mutation of a4 (Tapper
et al., 2004). The nAChR b4 subunit is almost always coex-
pressed with a3, while the auxiliary a5 subunit assembles with
the a3b4 combination, but can also be incorporated in a4b2
receptor complexes. The expression of the a3b4* nAChR combi-
nation is restricted to a few discrete brain areas, including the
medial habenula (MHb) and interpeduncular nucleus (IPN), and
to autonomic ganglia (Zoli et al., 1995). a3b4* nAChRs have
a lower affinity for nicotine than a4b2 receptors and are likely
less desensitized at the nicotine levels found in smokers than
a4b2 nAChRs are, suggesting that a3b4* nAChRs could play
an important role in tobacco addiction, since they retain their
sensitivity to fluctuating nicotine levels in smokers (Rose,
2007). b4 and a5 KO mice show similar phenotypes, including
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Determinants of a3b4a5 nAChRs in Nicotine Aversiondecreased signs of nicotine withdrawal symptoms (Jackson
et al., 2008; Salas et al., 2004, 2009), hypolocomotion, and resis-
tance to nicotine-induced seizures (Kedmi et al., 2004; Salas
et al., 2004). It has been more difficult to assess the role of a3*
nAChRs because KO mice die within 3 weeks after birth due to
severe bladder dysfunction (Xu et al., 1999).
Here we show that a3b4a5 nAChR activity in vitro and in vivo is
limited by the level of Chrnb4 expression, and that the ability of
the b4 subunit to increase a3b4a5 currents depends on a single,
unique residue (S435). This residue maps to the intracellular
vestibule of the nAChR complex adjacent to the rs16969968
SNP inCHRNA5 (D398N), which is linked to a high risk of nicotine
dependence in humans. We present a transgenic mouse model
of theChrnb4-Chrna3-Chrna5 gene cluster, referred to as Tabac
(transgenic a3b4a5 cluster) mice, in which Chrnb4 overexpres-
sion enhances a3b4* nAChR levels, resulting in altered nicotine
consumption and nicotine-conditioned place aversion (CPA).
Lentiviral-mediated transduction of the MHb of Tabac mice
with the D398N Chrna5 variant reversed the nicotine aversion
induced by b4 overexpression. This study provides a mouse
model for nicotine dependence, demonstrates a critical role
for the MHb in the circuitry controlling nicotine consumption,
and elucidates molecular mechanisms contributing to these
phenotypes.
RESULTS
The Relative Levels of a5 and b4 Subunits Strongly
Affect a3b4a5 nAChR Currents
Recently it has been shown that a5 competes with b4 for asso-
ciation with a4, and that this competition does not occur if b4
is substituted with b2 (Gahring and Rogers, 2010). Given that
the CHRNA5-A3-B4 gene cluster regulates the coexpression
of a5, b4, and a3 subunits, and that SNPs in the cluster regula-
tory regions and nonsynonymous variants such as rs16969968
(corresponding to D398N in CHRNA5) associate with nicotine
dependence (Bierut, 2010; Bierut et al., 2008; Saccone et al.,
2009), we were first interested in determining whether variation
of the proportion of a3, b4, and a5 (wild-type [WT] and D398N)
subunits influences nicotine-evoked currents. To measure
this, we performed electrophysiological recordings in oocytes
injected with cRNA transcripts of the different mouse subunits.
In these experiments (Figure 1), the cRNA concentration of a3
was held constant (1 ng/oocyte), whereas the concentration of
b4 or b2 input cRNA was varied among 1, 2, 3, 4, 5, or 10 ng.
These experiments showed that b4, but not b2, was able to
increase current amplitudes in a dose-dependent manner
(Figures 1A and 1B). b4 overexpression did not shift the dose
response curves for nicotine (Figure S1A, available online).
Next we held constant the concentrations of a3 and b4 at 1:10
and added the cRNA of a5WT or a5 D397N variant (correspond-
ing to the human a5 variant D398N) at ratios of 1:10:1, 1:10:5,
and 1:10:10 (Figure 1A). We observed a significant decrease of
current amplitudes at higher concentrations of a5, and this effect
was significantly more pronouncedwith a5D397N. These results
suggest that a5 and b4 may compete for binding to a3, in line
with the studies showing such competition for binding to a4
(Gahring and Rogers, 2010).Given that overexpression of b2 with either a3 (Figure 1A) or
a4 (Figure S1B) did not increase currents, we were interested
in identifying the residues differing between b4 and b2 that
mediate this effect. Since the long cytoplasmic loop is the
most divergent domain between nAChR subunits (Figure S1C),
and since it has been implicated in cell-surface expression
and trafficking of b2 subunits (Nashmi et al., 2003; Ren et al.,
2005), we generated b2–b4 chimeras exchanging either this
domain, or short motifs and single residues within this domain.
Replacement of the cytoplasmic loop of b2 with the correspond-
ing sequences present in b4 (b2/b4 322–496) led to strong
increase of nicotinic currents (Figure 1C). Introduction of two
b4-specific motifs (a serine/tyrosine rich motif [b2/+b4 382–
391] and gephyrin-like-binding motif [b2/+b4 401–419] into the
b2 loop) had no influence on current amplitudes (Figure 1C).
We next performed bioinformatic analyses and singled out eight
b4-specific residues (indicated as T-1 to T-8 in Figure S1C)
present within highly conserved motifs. Six of these residues
were not further considered: T-2, T-3, T-6, and T-7 residues
differ between mouse and chicken b4 subunits, which are
equally potent in enhancing nicotine-evoked currents (Fig-
ure S1B); T-4 residue lies within the tested motif in the b2/+b4
382–391 chimera; and residues at position T-8 have the same
charge (Figure S1C). The remaining two candidates, T-1 (S324
in b4 and T327 in b2) and T-7 (S435 in b4 and R431 in b2) (Fig-
ure S1C) were tested by point mutagenesis in the b2 subunit
backbone. The b2 T327S point mutant did not increase current,
whereas replacement of b2 R431 with serine resulted in a 3.5-
fold current increase (Figure 1C). Furthermore, point mutation
of the native S435 in the b4 subunit to the arginine residue pre-
sent in b2 (b4 S435R) abolished the b4-specific activity. Thus,
these data demonstrate that the distinctive ability of b4 to
increase currents when overexpressed maps to a single residue
(S435) that is required in b4 for current increase and can confer
this property to b2.
Electrostatic Mapping of the Intracellular Vestibule
of the a3b4a5 nAChR Complex
Alignment of mouse, human, and Torpedo nAChR subunit
sequences indicated that S435 in b4 and D397N in a5 are
located in the 25 amino-acid-long amphipathic membrane-
associated stretch (MA-stretch) described in the Torpedo sub-
units (Unwin, 2005) (Figure 2A). Electron microscopy studies of
the Torpedo nAChR have proposed a 3D density map of the
receptor complex. In particular, these analyses predict that
the MA-stretch of each subunit forms a curved a-helix that helps
create, with other a-helices, an inverted pentagonal cone vesti-
bule. To locate the S435 (b4) and D397 (a5) residues within the
receptor pentamer, we performed homology modeling with the
Torpedo nAChR using one possible a3b4a5 subunit arrange-
ment. This model predicted the formation of a very similar dispo-
sition of a helices in the a3b4a5 and mapped both residues to
the intracellular vestibule (Figure 2B). Electrostatic mapping of
the vestibule showed a particular disposition of charges with
S435 and D397 located at the more distal and positively
charged part of the vestibule (Figure 2C). These data indicate
first that the critical residue in b4 that mediates the b4 effect is
located in the receptor structure near the most common SNPNeuron 70, 522–535, May 12, 2011 ª2011 Elsevier Inc. 523
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Figure 1. Increase of nAChR Currents by b4 Is Competed by a5 and Maps to a Single Amino Acid (S435)
(A) Quantification of nicotine-evoked currents (100 mM, 20 s) recorded in Xenopus oocytes injected withmouse a3:b2, a3:b4, and a3:b4:a5 cRNAs at the indicated
ratios. Current amplitudes from 1:3 to 1:10 a3b4 combinations are significantly increased compared to 1:1 ratio (*p < 0.05 and ***p < 0.001). Addition of a5 to the
a3b4 complex leads to significant decrease of current amplitudes when equal amounts of b4 and a5 are injected (**p < 0.01 for WT a5 and ***p < 0.001 for a5
D397N). The D397N variant shows significantly stronger competition with b4 compared toWT a5 (*p < 0.05). Triangles indicate increasing relative amounts of one
specified subunit.
(B) Representative traces of two-electrode voltage-clamp recordings.
(C) Schematic representation of b2/b4 chimeras indicating the domains, motifs, or residues exchanged between b4 (in green) and b2 (in black) subunits and
corresponding amino acid number and substitutions (left). Fold current increase (right) indicates the relative current amplitude of nicotine-evoked currents for
each b2/b4 chimera expressed with the a3 subunit at 1:10 relative to 1:1. All values are expressed as mean ± SEM; n = 5 per ratio in all experiments.
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Determinants of a3b4a5 nAChRs in Nicotine Aversionof a5 to be associated with heavy smoking; and second, that
this is a highly charged domain of the receptor where single
residue changes may have a particularly strong effect on
receptor activity.524 Neuron 70, 522–535, May 12, 2011 ª2011 Elsevier Inc.Transgenic Mice of the Chrnb4/a3/a5 Gene Cluster,
or Tabac Mice
To test the hypothesis that b4 is rate limiting for nAChR assembly
and function in vivo and that overexpression of b4 can strongly
α3
β4
α5
 
B C
α3 α5
β4
D397S435
Vestibule
S435 D397
A
Chrnb4 HS 427-451
Chrnb4 MM 430-454
Chrnb2 HS 427-451
Chrnb2 MM 426-450
Chrna3 HS 444-468
Chrna3 MM 438-462
Chrna5 HS 396-420
Chrna5 MM 395-419
Chrna1 TC 399-423
Chrnb1 TC 428-452
Chrng   TC 433-457
Chrnd   TC 443-467
MA-strech
negative charge
positive charge
435
432
D397
α5
α3
398
397
Figure 2. Electrostatic Mapping of the Intracellular Vestibule of the a3b4a5 nAChR Complex
(A) Alignment of human (HS), mouse (MM), and torpedo (TC) sequences spanning theMA-stretch of the indicated nAChR subunits. The S435 residue in b4 and the
D397 residue in a5 are indicated by a black frame.
(B) Model of the 3D structure of the a32b42a51 nAChR. Transmembrane and intracellular domains of a3, a5, and b4 subunits are shown in orange, red, and green,
respectively. EC, extracellular space; IC, intracellular space. The indicated S435 residue in b4 and the D397 residue in a5 are located at the tip of the intracellular
vestibule.
(C) Electrostatic potential surface representations showing frontal (upper panel) and back (lower panel) views of the intracellular vestibule formed by the
a32b42a51 nAChR. One a3 subunit and one b4 subunit are removed for visualization of the cavity. Horizontal gray bars indicate the plasma membrane. The
electrostatic surface was contoured between 15kT/e and +15kT/e; negative and positive charges are marked in red and blue, respectively. Residues corre-
sponding to the b4-potentiating residue S435 and D397 in a5 are indicated.
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to nicotine, we characterized a bacterial artificial chromosome
(BAC) transgenic line spanning the Chrnb4-Chrna3-Chrna5
gene cluster (Gong et al., 2003). The BAC transgene included
the intact coding sequences of the Chrnb4 gene, modifiedsequences of Chrna3, and incomplete sequences of Chrna5.
Chrna3 was modified by insertion of an eGFP cassette followed
by polyadenylation signals at the ATG translation initiator codon
of Chrna3 (Figure 3A). The upstream sequences of Chrna5,
encoding exon 1 splice variants (Flora et al., 2000), are missingNeuron 70, 522–535, May 12, 2011 ª2011 Elsevier Inc. 525
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Figure 3. Tabac Mice Express Elevated Chrnb4 Transcripts in Chrna3/eGFP-Labeled Neurons
(A) Scheme of the modified mouse BAC containing the Chrnb4-Chrna3-Chrna5 gene cluster. Yellow boxes: exons; green box: eGFP cassette; white box:
polyadenylation signal (pA); black arrows: direction of transcription; red crosses: truncated transcription; cis-regulatory elements marked in red: conserved
noncoding region (CNR4), b430 enhancer (Xu et al., 2006); E1/E2: SP1 and SP3 binding sites (Bigger et al., 1997); and a3-i: transcriptional silencer (Medel and
Gardner, 2007).
(B) Western blot analyses of b4 (53 kD), a5 (two splice variants: 50 kD and 53 kD), and a-tubulin in brain extracts of WT and Tabac mice.
(C–H) eGFP-expressing neurons (green) in peripheral SCG (C) and in sagittal brain sections (except G: coronal) of Tabac mice immunostained with TH (D and E)
and ChAT (F–H) in red. Scale bars: (C) 100 mm; (D–F) 500 mm (magnification of D is indicated by the dotted lines; scale bar: 50 mm); (G) 50 mm; and (H) 250 mm.
(I and J) ISH of Chrnb4 transcripts in WT and Tabac brain sections. Scale bars: MHb, 100 mm; SuM, 50 mm; IPN, 250 mm; VTA, 100 mm.
TH, tyrosine hydroxylase; ChAT, choline acetyltransferase; MHb, medial habenula; fr, fasciculus retroflexus; VTA, ventral tegmental area; pAg, periaqueductal
gray; Cli, caudal linear nucleus; SuM, supramammilary nucleus; IPN, interpeduncular nucleus; LdT, laterodorsal tegmentum; SN, substantia nigra; SCG, superior
cervical ganglia.
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Determinants of a3b4a5 nAChRs in Nicotine Aversionin the BAC transgene (Figure 3A). To promote correct expression
of Chrnb4, the BAC included the intergenic and 50 flanking
regions encompassing the cis-regulatory elements that coordi-
nate cotranscriptional control of the genes in the cluster (Bigger526 Neuron 70, 522–535, May 12, 2011 ª2011 Elsevier Inc.et al., 1997;Medel andGardner, 2007; Xu et al., 2006). As a result
of these modifications in the BAC transgene, these Tabac mice
express high levels of b4, but not a5 (Figure 3B), and expression
of a3 is replaced by expression of an eGFP reporter cassette to
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Figure 4. TabacMice Show Increased Nico-
tine-Evoked Currents and Firing Frequency
in Chrna3/eGFP-Labeled Neurons
(A–F) Whole-cell patch-clamp recordings of MHb
neurons in acute brain slices from WT and Tabac
mice. Representative traces of nicotine-evoked
currents (A: 100 mM, 50 ms application) and cor-
responding concentration-response relationships
(B: peak amplitudes ± SEM, n = 5–8 cells per
genotype, p < 0.05 by two-way ANOVA). Dose-
response curves in (C) were calculated relative to
the maximal response to nicotine from (B). (D)
Mecamylamine (MEC, 3 mM, 3 min) inhibition of
nicotine-evoked currents in neurons of Tabac
mice. Representative current clamp recordings (E)
and quantification of action potentials upon local
application of nicotine (1 mM, 3 s) in neurons of WT
and Tabac mice are shown in (F) (mean firing
frequency ± SEM, n = 4, p < 0.01). Numbers in
parenthesis represent number of neurons tested.
All values are expressed as mean ± SEM.
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shown in Figure 3, neurons expressing eGFP were evident in
autonomic ganglia (Figure 3C), and in very restricted brain struc-
tures (Figures 3D–3H) known to express these genes (Zoli et al.,
1995). Immunostaining with cholinergic (ChAT) and dopami-
nergic (TH) markers indicated high expression of Chrna3/eGFP
in ChAT neurons of the Hb-IPN system (Figures 3G and 3H).
Intense Chrna3/eGFP expression was also detected in other
brain areas (Figures 3D and 3E) involved in nicotine addiction,
such as the ventral tegmental area (VTA), the caudal linear
nucleus (Cli), the supramammilary nucleus (SuM) (Ikemoto
et al., 2006), and the laterodorsal tegmental nucleus (Figure 3F),
which provides modulatory input to the VTA (Maskos, 2008). We
performed in situ hybridization (ISH) experiments to verify that
the BAC accurately directed expression of transgenic Chrnb4
transcripts to eGFP-positive brain areas. Tabac mice showed
a prominent enrichment of Chrnb4 transcripts in a3b4*-positive
areas, such as MHb and IPN, and in brain areas that have
been shown to express lower levels of Chrnb4, such as SuM
(Dineley-Miller and Patrick, 1992) and VTA (Yang et al., 2009)
(Figures 3I and 3J). RT-PCR studies showed that Chrna4,
Chrna7, and Chrnb2 transcripts (which are not present in the
BAC) are not altered in Tabac mice (Figure S2). Taken together
these data show that Tabac mice express high levels of b4, but
not a5, in a3/eGFP-labeled cells in CNS and PNS structures
known to express the Chrnb4-Chrna3-Chrna5 nicotinic gene
cluster, and are thus a useful mouse model in which to test the
consequences of enhanced b4 expression at endogenous sites.
Increased Nicotine-Evoked Currents in Transgenic
Tabac Mice
Given the demonstration that the level of b4 expression is rate
limiting for the function of a3b4a5 receptors in vitro (Figure 1),
we were next interested in determining whether enhancedexpression of Chrnb4 in Tabac neurons resulted in elevated
nicotine-evoked currents in vivo. Previous studies have shown
that neurons in the MHb express high levels of a3b4a5 receptors
(Quick et al., 1999). Accordingly, we employed patch-clamp
recordings tomeasure nicotine-evoked currents inMHb neurons
of Tabac mice. A large proportion of MHb neurons in WT mice
(n = 20 of n = 23 neurons recorded) responded to local fast
application (50 ms) of nicotine (Figures 4A and 4B). In Chrna3/
eGFP-labeled MHb neurons of Tabac mice, nicotine elicited
significantly increased peak currents in comparison to WT litter-
mates (on average, 3.4-fold at 100 mMnicotine, two-way ANOVA,
p < 0.05) (Figure 4B). Similarly increased responses were
obtained using acetylcholine (ACh) (data not shown). Dose-
response curves for nicotine showed no significant differences
between WT and Tabac mice, indicating that the affinity of the
receptors in the transgenic mice is not altered (Figure 4C). Appli-
cation ofmecamylamine (MEC), a nonselective potent inhibitor of
a4b2* and a3b4* nAChRs (Bacher et al., 2009), resulted in
a blockade of as much as 90% of the nicotine-elicited responses
inTabacmice (Figure 4D), demonstrating that theenhancednico-
tine responses in Tabac neurons result directly from elevated
levels of functional nAChRs. To determine whether these addi-
tional receptors cause enhanced neuronal excitability, the firing
rate of habenular neurons was measured in current-clamp
assays in response to nicotine. Neurons from WT and Tabac
mice were silent at rest (70 mV). Local nicotine application
(1 mM for 3 s) elicited single action potentials in WT neurons,
whereas nicotine induced a robust burst of action potentials
with a 13-fold higher firing frequency on average in Tabac
neurons (p < 0.005) (Figures 4E and 4F). Together, these results
indicate that the increased sensitivity of MHb neurons to nicotine
in Tabac mice results from the presence of additional functional
nAChRs, rather than from changes in the nicotine affinity of
existing receptors.Neuron 70, 522–535, May 12, 2011 ª2011 Elsevier Inc. 527
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Binding Sites
To assay for elevated receptor expression across different brain
structures, we performed autoradiographic radioligand binding
assays with iodinated epibatidine, which mainly binds a4b2*
and a3b4* nAChRs (Perry and Kellar, 1995) (Figures 5A and
5B). Competition with cold cytisine, which binds with higher
affinity to a4b2* than to a3b4* receptors (Marks et al., 2010),
was done to distinguish a3b4* from overlapping a4b2* binding
sites (Zoli et al., 1998) (Figures 5C and 5D). In WT mice, discrete
brain regions resistant to cytisine competition labeled well-
known a3b4* sites such as MHb, IPN, and superior colliculus
(Figure 5C). In Tabac mice, increased radioligand binding to
cytisine-resistant sites was detected in these areas and in
additional brain structures, including the VTA, SuM, substantia
nigra, and striatum (Figure 5D). A strong correlation between
radioligand signal and eGFP fluorescence was detected in all
analyzed CNS structures (Figure 5E and Table S1). Densito-
metric analyses indicated significantly increased cytisine-resis-
tant signals in a3b4*-expressing regions in Tabac mice (Table
S1), while a4b2* epibatidine binding sites such as cortex and
thalamus did not differ between control and Tabac mice (Figures
5A and 5B), indicating that elevated surface receptors are
present in sites corresponding to endogenous b4 expression
sites. To exclude the possibility that the increased radioligand
signal could reflect increased cell number, we quantified the
cell density in MHb of Tabac and WT mice and observed no
significant differences (Figure S3). These data show that the
enhanced nicotine-evoked currents in Tabac mice result from
b4-mediated recruitment of additional functional a3b4* nAChR
complexes on the cell surface.
Taken together, the anatomic mapping and ISH results pre-
sented in Figure 3 and the receptor binding assays presented
in Figure 5 provide compelling evidence that a3b4* nAChRs
are located both on the cell soma and in the axon termini. For
example, the relatively light staining of the IPN by ISH in Tabac
mice strongly suggests that the very heavy expression of func-
tional a3b4* receptors, detected in this structure by receptor
binding, results from both local synthesis in the IPN and the pres-
ence of receptors synthesized in the MHb and transported to
presynaptic termini in the IPN. This is consistent with the well-
documented effects of presynaptic nAChRs on synaptic release
and neurotransmission (McGehee et al., 1995), and suggests
that Tabac mice will be an important tool for further dissection
of the roles of presynaptically and postsynaptically expressed
nAChRs.
Tabac Mice Show a Strong Aversion to Nicotine
Consumption and Display Nicotine-CPA
Wewere next interested in the effects of elevated nAChR expres-
sion on the behavioral responses of Tabac mice to nicotine.
Measurements of drinking volumes showed that Tabac mice
consumed significantly less nicotine-containing-water than WT
littermates did (Figures 6A and 6B). Because nicotine solutions
have a bitter taste, nicotine was diluted in saccharin solution,
and control experiments were performed with a bitter solution
(containing quinine). There were no differences in consumption
of regular, sweetened, or bitter water between the two groups528 Neuron 70, 522–535, May 12, 2011 ª2011 Elsevier Inc.(Figure 6A). Next, we performed a free choice consumption
experiment where mice were allowed to choose between regular
water and water supplemented with different concentrations
of nicotine (1–100 mg/ml) without saccharin. Analysis of the
nicotine volume consumed relative to the total fluid intake (Fig-
ure 6C) indicated that Tabac mice significantly avoided drinking
nicotine solutions containingmore than5mg/ml nicotine (p<0.05,
two-wayANOVA),whileWTmice showednopreferencebetween
water and nicotine solutions below 50 mg/ml and avoided
drinking the highest concentration of nicotine solution tested. It
is possible that the decrease in drinking is due to negative conse-
quences of hyperactivation of the autonomic nervous system,
leading to gastric distress or nausea. However, we observed no
significant differences in body weight (Figure 6D), micturition,
and digestion (Figure S4) before and during the nicotine con-
sumption experiments.
As an independent measure of the effects of nicotine in Tabac
mice, CPA assays were performed. Because conditioning to
nicotine is both concentration and strain dependent (O’Dell
andKhroyan, 2009)wemeasuredCPA inWTC57BL/6 littermates
at 0.5 mg nicotine/kg body weight. Under these conditions, we
observed neither a preference for nor aversion to nicotine. In
contrast, strong CPA to nicotine was observed in Tabac mice
(Figure 6E). These data both confirm the conclusions of the nico-
tine consumption assays, and demonstrate that negative reward
learning associated with nicotine is strongly increased in Tabac
mice. We conclude that overexpression of the b4 subunit
in vivo leads to an increase in functional a3b4* receptors, result-
ing in a higher sensitivity to the aversive properties of nicotine.
Lentiviral-Mediated Expression of the a5 D397N Variant
in the MHb Reverses Nicotine Aversion in Tabac Mice
The observations that the a5 D397N variant reduces a3b4a5
nicotine-evoked currents in oocytes (Figure 1), and that the
MHb-IPN tract contains a high density of native a5 nAChR
subunits in combination with a3b4 subunits (Figure 3), suggested
that the enhanced nicotine aversion evident in Tabac mice could
be reversed by expression of the a5 variant in the MHb. To test
this hypothesis we employed lentiviral-mediated transduction
to express the a5 D397N in MHb neurons of Tabac mice. We
injected bilaterally either control lentivirus (LV-PC) or the LV-a5
D397N (LV-a5N) viruses in Tabac mice. As shown in Figure 7B,
immunostaining for the mCherry reporter of LV-a5N expression
or direct fluorescence derived from the control lentivirus demon-
strated that the lentiviral-transduced area corresponds with that
occupied by a3b4*/eGFP-labeled neurons in the MHb of Tabac
mice. Given that the maximal difference in nicotine consumption
in Tabac mice occurred at 25 mg/ml nicotine (Figure 6C), mice
were again given a two-bottle choice test to measure nicotine
aversion. These experiments were performed in Tabac mice
backcrossed to the inbred mouse line C57BL/6 (Figure 7C),
which has been shown to have a high basal level of self-selection
of nicotine (Glatt et al., 2009;Meliska et al., 1995; Robinson et al.,
1996), and in Tabac mice outbred between FBV/N mixed and
Swiss Webster (Figure 7D). As shown in Figure 7C, in C57BL/6
Tabac mice, injection of the LV-a5N virus reversed their nicotine
aversion in comparison to mice injected with the control virus. In
outbred Tabac mice injected with the control virus, we observed
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Figure 5. Increased Number of a3b4* nAChR Binding Sites in Tabac Mice
(A and B) Film autoradiograms of [125I]-epibatidine binding to a3b4* and a4b2* sites in WT (A) and Tabac (B) coronal brain sections.
(C and D) Detection of a3b4* sites (arrows) by competition of [125I]-epibatidine binding with unlabeled cytisine.
(E) Direct fluorescence (green) of Chrna3/eGFP-positive cell populations and immunostaining of coronal brain sections from Tabac mice with the indicated
antibodies (red: TH, NeuN, Substance P [SP], and CD28). Scale bars from top to bottom are 50, 25, 50, 25, 250, and 50 mm.
Mi, mitral cells; Gl, granule layer; aOB, accessory olfactory bulb; mPO, medial preoptic area; S1, primary sensory cortex layer IV; Pir, piriform cortex; Hip,
hippocampus; Am, amygdala; STh, subthalamic nucleus; sc, superior colliculus; PMR, paramedian raphe nucleus; Cb, cerebellum; arrow, basket cells; insert,
parallel fibers; RMg, nucleus raphe magnus; and MVe, medial vestibular nucleus Other abbreviations are the same as in Figure 1.
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Determinants of a3b4a5 nAChRs in Nicotine Aversionno alteration in nicotine aversion (Figure 7D) with respect to
uninjected Tabac mice (Figure 6C). Importantly, infection with
LV-a5N virus reversed nicotine aversion in Tabac mice(Figure 7D), restoring nicotine consumption ina5D397N-infected
Tabacmice to levels evident inWTmice (Figure6C). These results
demonstrate a major role for the MHb in nicotine consumption.Neuron 70, 522–535, May 12, 2011 ª2011 Elsevier Inc. 529
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Figure 6. Tabac Mice Consume Less Nicotine and Show Condi-
tioned Place Aversion
(A and B) Nicotine consumption in a no-choice paradigm (one drinking bottle).
(A) Drinking volumes (ml/mouse/day) of water, sweet water (2% saccharine),
and bitter water (5 mM quinine). The tested period of consumption was 3 days
(paired t test, #p < 0.05). (B) The dose of nicotine consumed expressed as the
milligrams of nicotine consumed per day considering the body weight of the
mouse (mg/kg/d) (p < 0.05). WT: n = 10, Tabac: n = 10.
(C) Nicotine consumption in a two-bottle choice paradigm between water and
water containing the indicated nicotine concentrations expressed as percent
of the volume of nicotine solution consumed divided by the total fluid intake per
day. Each concentration was tested for 3 days. Dashed line at 50% indicates
no preference. WT mice, n = 7; Tabac mice, n = 6; two-way ANOVA, p < 0.05.
(D) Body weight of WT and Tabac mice after nicotine drinking tests.
(E) Nicotine administration (0.5 mg/kg) elicits place aversion to a nicotine-
paired environment in Tabac mice. Following conditioning, Tabac mice
preferred the saline-paired environment over the nicotine-paired environment
(paired t test, #p < 0.05). WTmice spent significantly more time in the nicotine-
paired environement compared to Tabac mice (*p < 0.05) (WT mice, n = 7;
Tabac mice, n = 6). Data are expressed as time spent in drug-paired envi-
ronments after drug conditioning. All values are expressed as mean ± SEM.
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Human genetic studies have established an association
between the CHRNB4-CHRNA3-CHRNA5 locus and tobacco
use (Amos et al., 2010b; Saccone et al., 2009; Thorgeirsson
et al., 2008; Weiss et al., 2008). Here we report a mouse model
(Tabacmice) with altered nicotine consumption and CPA caused
by elevated levels of b4, enhanced nicotine-evoked currents,
and increased surface expression of functional nAChRs at
endogenous sites. The ability of b4 to enhance nicotine-evoked
currents depends on a single critical residue (S435) located in the
intracellular vestibule of the receptor. Interestingly, modeling
studies revealed that one of the most common SNPs associated
with tobacco usage, D398N in the a5 subunit, also maps to this
domain. Functional analyses of this variant demonstrate that
alterations in this domain can result in profound effects on nico-
tine-evoked currents. Based on our studies in Tabac mice in
which enhanced current is associated with increased aversion
to nicotine, we predicted that the a5 variant (corresponding to
D397N inmice) should increase nicotine consumption consistent
with its associationwith smoking. To test this idea, and given that
the MHb contains a very high concentration of endogenous
a3b4a5 receptors and elevated levels of b4 driven by the Tabac
transgene, we introduced the a5 variant by viral-mediated trans-
duction in habenular neurons of Tabac mice. The reversal of the
nicotine aversion achieved in Tabac mice observed in these
experiments demonstrates that the MHb plays a major regula-
tory role in nicotine consumption.
Three main points are addressed in this study. First, changes
both in the coordinated expression of a3b4a5 subunits (i.e.,
overexpression of the b4 subunit) and in single residues (i.e.,
in vivo viral-mediated expression of the a5 D397N variant)
have a strong influence on nicotine consumption in mice. This
is consistent with recent GWAs that have identified SNPs in
both regulatory and coding regions of the CHRNB4-CHRNA3-
CHRNA5 gene cluster that are associated with nicotine depen-
dence (Levitin et al., 2008; Saccone et al., 2009; Thorgeirsson
et al., 2008). Thus, our studies provide a model for further explo-
ration of the involvement of a3b4a5 nAChR function in nicotine
consumption. Second, our studies demonstrate that the intracel-
lular vestibule of the a3b4a5 receptor exerts an important effect
on nicotine-evoked currents. The high concentration of charges
in this membrane-associated domain is conserved in the super-
family of Cys-loop receptors (Carland et al., 2009; Kelley et al.,
2003; Unwin, 2005). Electrostatic calculations by homology
with the Torpedo nAChR predict that a3b4a5 receptors form
a highly electronegative vestibule most likely to promote a
stabilizing environment for cation outflow. The change in current
amplitude produced by substitutions of charged residues
(S435R and D397N) in this domain of the receptor predicts that
alterations of the electrostatic charge of the vestibule are critical
for receptor function. This is consistent with studies of the inner
vestibule in other Cys-loop receptor channels. For example, in
5HT3A receptors substitution of arginine-positive residues
increased channel conductance, whereas introduction of basic
residues in this domain of a1 glycine receptors decreases
glycine-evoked currents (Carland et al., 2009; Kelley et al., 2003).
Numerous reports have linked the a5 D398N polymorphism to
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Figure 7. Reversal of Nicotine Aversion in Tabac Mice by Lentiviral-Mediated Expression of the a5 D397N Variant in the MHb
(A) Schematic representation of the lentiviral (LV) constructs used for brain stereotactic injections. LV-a5N carries the mouse a5 variant D397N followed by
an IRES and the mCherry reporter. The control virus (LV-PC) carries mCherry fused to the N terminus of the transmembrane domain of the PDGF receptor
(TM-PDGF) via a linker domain.
(B) Coronal brain sections of Tabac mice stereotactically injected in the MHb with the indicated lentivirus. Colocalization of eGFP fluorescence driven by the
transgene in Tabac mice and mCherry red fluorescence for LV-PC or mCherry immnofluorescence for LV-a5N injected mice is shown. Scale bars: 100 mm.
(C and D) Two-bottle choice nicotine consumption in Tabac mice after stereotactic bilateral injection of control (LV-PC) and mutated a5 (LV-a5N) lentiviral
constructs in the MHb. Tabac mice were backcrossed to C57BL/6; n = 4 for LV-PC and n = 5 for LV-a5N, p < 0.05 (C), and Tabac mouse hybrid of FVB/N and
Swiss Webster (n = 8 for LV-PC and n = 9 for LV-a5N) is shown in (D).
All values expressed are mean ± SEM.
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Determinants of a3b4a5 nAChRs in Nicotine Aversionsmoking incidence (Bierut, 2010; Bierut et al., 2008; Saccone
et al., 2009). Incorporation of D398N a5 variant into a4b2-con-
taining receptors in transfected cells results in a 2-fold reduction
in epibatidine-evoked calcium currents without a change in
surface expression (Bierut et al., 2008), consistentwith the reduc-
tion in nicotine-evoked current amplitudes reported here upon
incorporation of this variant into a3b4-containing nAChRs. Taken
together, these observations support the hypothesis that substi-
tution of this charged residuemodifies the vestibule electrostatic
charge, but not the number of receptors incorporated into the
plasma membrane. In contrast, the increase in receptor surface
expression in Tabacmiceand the identification of a single residue
in the b4 subunit (S435R) that is both essential for the increase
of currents observed in this study upon overexpression of the
b4 subunit, and that can confer this property upon b2 subunits,suggest that the b4 subunit is rate limiting for the formation of
a3b4a5 nAChRs. Although the precise role of S435 is not yet
clear, it may be involved in stabilization of nAChR complexes,
export of the receptors from the ER due to interactions with traf-
ficking proteins, or alterations in its turnover from the cell surface.
For example, rapsyn binding to the a-helical domains corre-
sponding to the inner vestibule of the a1b1gd nAChR is required
for surface expression of this receptor (Lee et al., 2009), and
binding of UBXD4 to the cytoplasmic loop of a3 can interfere
with its ubiquitination and, consequently, the number of a3-con-
taining receptors at the cell surface (Rezvani et al., 2010). Thus,
our studies point to two mechanisms mediated by specific resi-
dues in the inner vestibule, one leading to ion permeation
changes within a single a3b4a5 receptor, and the other leading
to increased surface expression of receptors by native b4.Neuron 70, 522–535, May 12, 2011 ª2011 Elsevier Inc. 531
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Determinants of a3b4a5 nAChRs in Nicotine AversionThird, the studies presented here demonstrate that the MHb
has a major influence in the control of nicotine consumption,
extending previous studies of the role of the Hb in nicotine
withdrawal and drug addiction (Jackson et al., 2008; Salas
et al., 2004, 2009; Taraschenko et al., 2007) and, recently, in
nicotine self-administration (Fowler et al., 2011). Although
multiple interconnected brain regions, including the prefrontal
cortex, VTA, thalamus, striatum, and amygdala are affected by
chronic use of nicotine, the habenular system is emerging as
an important station in pathways regulating the behavioral
effects of nicotine (Changeux, 2010; De Biasi and Salas, 2008;
Rose, 2007). The MHb projects mainly to the IPN, which, in
turn, seems to inhibit the motivational response to nicotine
intake. Thus, inactivation of the MHb and IPN both result in
increased intake of nicotine (Fowler et al., 2011). Consistent
with these studies, overexpression of b4 results in enhanced
activity of the MHb, resulting in the opposing effect, e.g., aver-
sion to nicotine. Reversal of nicotine aversion in Tabac mice
overexpressing b4 is achieved by expression of the a5 D397N
in MHb neurons. Similarly, a5 re-expression in the Hb of a5 KO
mice normalizes their nicotine intake (Fowler et al., 2011). Taken
together, these studies provide direct evidence that the MHb
acts as a gatekeeper in the control of nicotine consumption
and that the balanced contribution of b4 and a5 subunits is crit-
ical for this function. Further analyses of nAChR function in the
habenulo-IPN tract and its associated circuitry will be required
to fully understand the addictive properties of nicotine.EXPERIMENTAL PROCEDURES
Two-Electrode Voltage-Clamp Recordings of Xenopus Oocytes
cDNA clones of the nAChR mouse subunits a3, a4, a5, b2, and b4 were subcl-
oned into pCS2+ plasmid for Xenopus oocyte expression and in vitro tran-
scribed with T7 or SP6 RNA polymerases (mMESSAGE mMACHINE, Ambion,
Austin, TX) as described in Iban˜ez-Tallon et al. (2004). b4 S435R, a5 D397N,
and b2/b4 chimeras were cloned using a Mutagenesis Kit according to the
manufacturer’s instructions (Stratagene). Oocytes were surgically removed
and prepared as described (Stu¨rzebecher et al., 2010). Each oocyte was
injected with 20 nl of a cRNA mix containing either 1 ng or 10 ng of one a and
one bnAChRsubunit in 1:1, 1:2, 1:3, 1:4, 1:5, 1:10, and 10:1 ratios. In a separate
experiment, a5WT and a5 D397Nwere coinjected at 1:10:1, 1:10:5, or 1:10:10
ratios (a3:b4:a5). Macroscopic currents were recorded between 2 and 5 days
after injection with a GeneClamp 500B amplifier (Axon Instruments) using
a two-electrode voltage clamp with active ground configuration. Electrodes
(0.5–2 MU) were filled with 3M KCl. The extracellular recording solution
contained 82.5 mM NaCl, 2 mM KCl, 1 mM CaCl2, 1 mM MgCl2, and 10 mM
HEPES at pH 7.4. Nicotine-tartrate (Sigma-Aldrich) was prepared in extracel-
lular solution at concentrations of 10 nM to 100 mM. Solutions were gravity
fedwith a flow rate of5ml/min using aBath Perfusion System valve controller
(ALA-VM8, ALA Scientific Instruments). Data were acquired using pCLAMP9
software (Axon Instruments) and currents were sampled at 10 Hz. Membrane
potential was clamped to 70 mV; only oocytes with leak currents <100 nA
were used. Mean fold current increase was evaluated by dividing peak ampli-
tudes of 5–10 single oocytes at each ratio by peak amplitudes at 1:1 ratio. All
experiments were repeated twice. Dose-response curves were calculated
relative to the maximal response to nicotine as described in Iban˜ez-Tallon
et al. (2002).
Molecular Modeling
All models of pentameric a3a5b4 nAChR and single-residue variations were
constructed with the program MODELER 9v7, using the structure of the
nAChR from T.marmorata (PDB ID 2BG9) as a template for modeling. Energy532 Neuron 70, 522–535, May 12, 2011 ª2011 Elsevier Inc.equilibration and dynamics calculations were performed using GROMACS
3.3.3 applied to a pentameric a3a5b4 nAChRwithout the extracellular domain.
After relaxation in an energy equilibration in OPLS-AA force field, the nAChR
structures were compared.
Animals
Transgenic Tabac reporter mice were generated as described (Gong et al.,
2003). Briefly, a BAC RP23-33606, containing the mouse Chrnb4, Chrna3,
and Chrna5 nicotinic receptor gene cluster, was recombined using a BAC
engineering system by introducing an eGFP and a polyadenylation signal
directly upstream of the coding sequence of the Chrna3 gene. The modified
BAC was injected into pronuclei of FVB/N fertilized oocytes, and hemizygous
progeny was mated to Swiss Webster mice each generation thereafter. For
stereotactic injection experiments and CPA, mice were backcrossed to
C57BL/6 for six generations. All transgenic animals used for experiments
were heterozygous. Mice were housed with ad libitum access to food and
water in a room air conditioned at 22C–23C with a standard 12 hr light/
dark cycle, with a maximum of five animals per cage. All procedures were in
accordance with ethical guidelines laid down by the local governing body.
Western Blotting
Western blotting procedure was adapted from Grady et al. (2009). Briefly, the
MHb was dissected from adult Tabac and WT mice (n = 3 per genotype),
collected in 1 ml of lysis buffer (50 mM Na phosphate [pH 7.4], 1 M NaCl,
2 mM EDTA, 2 mM EGTA, and protease inhibitor cocktail), and immediately
homogenized by passing the tissue 10 times through a syringe (27G). The
homogenates were centrifuged for 30 min at 13,000 rpm and the pellet was
resuspended in 500 ml of 50 mM Tris HCl [pH 7], 120 mM NaCl, 5 mM KCl,
1 mM MgCl2, and 2.5 mM CaCl2 containing protease inhibitor cocktail. After
addition of 2% Triton X-100, the membranes were extracted for 2 hr at 4C.
Supernatants were recovered after 10 min of centrifugation. Equal amounts
of membrane extracts underwent SDS-PAGE and were transferred to PVDF
membranes. Primary antibodies used were rabbit anti-beta4 (gift from
Dr. Cecilia Gotti), mouse monoclonal (268) alpha5 mAb (Abcam, Cambridge,
UK), or mouse monoclonal anti-a-tubulin (Sigma, St Louis, MO). After incuba-
tion with the appropriate HRP-conjugated secondary antibodies, peroxidase
was detected using a chemiluminescent substrate (Pierce, Rockford, IL).
Brain Immunohistochemistry
Adult mice were injected with a lethal dose of ketamine and perfused transcar-
dially with 4% paraformaldehyde in cold 0.1 M phosphate buffer (PB). Brains
were fixed for 2–4 hr and transferred to 30% sucrose in PB. The next day,
40 mm coronal or sagittal sections were cut from a dry ice-cooled block on
a sliding microtome (Leica) and kept in cryoprotectant (25% ethylene glycol,
25% glycerol, and 0.05 M PB) at 20C until immunofluorescence labeling
was performed. Selected brain sections were washed in PBS and pretreated
with blocking buffer (0.3% Triton X-100 and 10% horse serum in phosphate
buffered saline). All antibodies were diluted in PBT containing 0.3% Triton
X-100 and 1% horse serum in PBS. Primary antibodies used were rabbit
polyclonal anti-eGFP (Molecular Probes) and goat polyclonal anti-ChAT
(Chemicon), both diluted 1:1000; rabbit polyclonal anti-calbindin D-28K (Swint)
diluted 1:500; rabbit polyclonal anti-Substance P (Zymed) diluted 1:1000; or
mouse monoclonal anti-Tyrosine hydroxylase (Sigma-Aldrich) diluted 1:2000
and incubated overnight at 4C. Costaining with anti-eGFP was necessary
to detect fluorescent signals in weakChrna3 expression areas (e.g., substantia
nigra and VTA) and to visualize axonal/dendritic processes. Secondary anti-
bodies used were goat anti-mouse IgG conjugated with Cy3 (Jackson) and
donkey anti-goat IgG conjugated with Alexa Fluor 555 (Molecular Probes),
both diluted 1:500 and incubated 2 hr at RT. Sections were washed, mounted
on slides, and coverslipped in immu-mount (Thermo Scientific). Fluorescent
signals were detected using a confocal laser scanning microscope (Leica
SP5). A Biorevo fluorescent microscope (Keyence) was used for low-magnifi-
cation pictures.
ISH
A mouse brain cDNA library was used to amplify bases 982–1382 from
Chrnb4 and subcloned into the TOPO TA pCR2.1 vector (Invitrogen). After
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merase and labeled with DIG according to the manufacturer’s instructions
(Roche Applied Science). ISH was performed on 20 mm coronal sections
from WT and transgenic littermates as described before (Auer et al., 2010).
The developing enzymatic color-reaction was stopped simultaneously in
sections of WT and transgenic mice.
Acute Brain Slice Electrophysiological Recordings
Whole-cell patch-clamp recordings were made in coronal slices (250 mm) con-
taining the MHb from WT and transgenic mice (P7–P14). Acute brain slices
were cut with a vibratome (Microm HM 650 V) and kept in ice-cold oxygenated
(95% O2 and 5% CO2) artificial cerebrospinal fluid (ACSF) containing (in mM)
125 NaCl, 2.5 KCl, 1.3 MgCl2, 2 CaCl2, 1.25 KH2PO4, 11 glucose, and
26 NaHCO3 (pH 7.4, osmolarity 310) and allowed to recover for at least 1 hr
in oxygenated ACSF at RT. The recording chamber was gravity fed with the
same buffer. Hb neurons were visually identified with a microscope (Axioskop
2 FS plus) equipped with a digital camera (SPOT Insight). Patch electrodes
were made from borosilicate glass (1B150F-4, World Precision Instruments,
Inc.) with a microelectrode puller (P-97, Sutter Instrument, CO). The internal
pipette solution contained (in mM) 130 KCl, 2 MgCl2, 0.5 CaCl2, 5 EGTA,
and 10 HEPES (pH 7.3, osmolarity 280; resistance, 5–7 MU). Typical series
resistance was 15–30 MU. Nicotine was locally applied (50 ms, 8–10 psi) at
different concentrations (1–600 mM) with a pressure device (PR-10, ALA
Scientific Instruments) connected to a focal perfusion system (VM4, ALA
Scientific Instruments) controlled with a trigger interface (TIB 14S, HEKA).
The pipette was moved within 15–20 mm of the recorded cell with a motorized
micromanipulator (LN mini 25, control system SM-5, Luigs & Neumann) for
drug application and retracted after the end of the puff to minimize desensiti-
zation. In current clamp, the pipette with nicotine was positioned 100 mm from
the cell and the drug was applied for 3 s. Neurons showing spontaneous
oscillations were not tested. Currents were recorded with a HEKA amplifier
(EPC 10) using PatchMaster software (V2.20, HEKA), and were analyzed with
FitMaster software (V2.3, HEKA). Membrane potential was held at 70 mV.
Dose-response curves were calculated relative to the maximal response to
nicotine (n = 3 cells per genotype).
Receptor Ligand Autoradiography
Adult brains were dissected and immediately embedded in O.C.T. compound
(Sakura). Frozen tissues were cut at the cryostat (20 mm coronal sections),
thaw mounted on ultrafrost microscope slides (Menzel Gla¨ser), and stored at
80C. For total [125I]-epibatidine binding sites, sections of WT and transgenic
littermates (n = 3 per genotype) were incubated with 200 pM [125I]-epibatidine
(NEN Perkin Elmer, Boston; specific activity 2200 Ci/mmole) in Tris 50 mM
(pH 7.4) for 1 hr. For cytisine-resistant [125I]-epibatidine binding sites, sections
were first incubated with 25 mM Cytisine (Sigma, St Louis) in Tris 50 mM
(pH 7.4) for 30 min, as described previously (Zoli et al., 1995). Quantification
of binding was done with ImageJ (NIH).
Oral Nicotine Consumption: No-Choice Paradigm
WT (n = 5) and Tabac (n = 5)malemice were single housed in their home cages.
Mice were provided with either nicotine or saccharin solutions as their sole
source of fluid and bottles were weighed daily to measure nicotine intake.
The volume of the drinking solution consumed per day was averaged for the
period of consumption (3 days). Drinking solutions were: water, 2% saccharine
in water (sweet water), 5 mM quinine (bitter water), or 100 mMnicotine in sweet
water. Nicotine tartrate was dissolved in 0.9% sterile saline (all concentrations
of nicotine refer to the free base form). The dose consumed was calculated as
the milligrams of nicotine consumed per day considering the body weight of
the mouse (mg/kg/d).
Oral Nicotine Consumption: Free-Choice Paradigm
Voluntary nicotine intake was assessed in adult male WT (n = 7) and Tabac
(n = 6) mice, using the two-bottle assay as described before (Butt et al.,
2005). Naive mice were presented with two bottles of water in the home
cage for acclimatization to the new conditions for the first 3 days of testing.
After this period, one of the bottles was filled with a nicotine solution (1 mg/ml)
diluted in water. The intake of fluid from each bottle was measured daily for3 days. The concentration of the nicotine solution was then increased and
tested for another 3 days. In total, six different concentrations were tested
consecutively (1, 5, 12.5, 25, 50, and 100 mg/ml). Percent of nicotine consump-
tion was expressed as a ratio of the volume of nicotine solution consumed
divided by the total fluid intake ([ml nicotine 3 100%]/ml total).
CPA
The CPA apparatus used was a rectangular box composed of three distinct
compartments separated by removable doors. The center compartment
(10 3 20 3 10 cm) is gray with a polycarbonate smooth floor. The choice
compartments (20 3 40 3 20 cm) have different visual and tactile cues. One
choice compartment has black walls with a 0.75 cm stainless steel mesh floor.
The other compartment has white walls with a 0.25 cm stainless steel mesh
floor. Behavior of animals was videotaped and scored by a blind observer.
In the preconditioning phase, on day 1, mice (8–12 weeks old) were allowed
to explore the three compartments freely for 15 min. This preconditioning
session was used to separate mice into groups with approximately equal
biases for each side. None of the mice exhibited a strong preference for one
side over the other. In the conditioning phase, during the following 3 days,
two pairings per day were given at 4–5 hr apart. The doors between the
compartments were closed so that animals were confined to one side or the
other of the conditioning box for 15 min. In the morning the animals were given
an i.p. saline injection prior to the placement in the chamber. In the afternoon,
animals received a nicotine injection (i.p., 0.5 mg/kg) prior to the placement in
the opposing chamber. In the preference test, on day 5, the doors between the
compartments were opened again. Mice were placed in the central chamber
and were allowed to move freely in the three chambers for 15 min. Time spent
on each side was recorded.
Lentivirus Production
Recombinant lentiviral vectors were prepared using transient transfection of
HEK293T cells. Briefly, 5 3 106 HEK293T cells were seeded on 24 3 10 cm
cell-culture dishes precoated with poly-L-lysine (Sigma-Aldrich). The next
day, the transfer vector plus the packaging vectors pLP1 and pLP2 (ViraPower
System; Invitrogen) and the envelope vector pCMV-VSV-G (Addgene) were
cotransfected with PEI transfection (Polyethylenimine MAX, Polysciences
Inc.) into HEK293T cells. The transfection mix was prepared as follows (for
one dish): 12 mg transfer plasmid, 6.5 mg pLP1, 3.5 mg pLP2, and 3.5 mg
pCMV-VSV-G were added to 800 ml OptiMEM (GIBCO) and incubated at RT
for 5 min. In the meanwhile, 51 ml PEI solution (1 mg/ml) was added to 800 ml
OptiMEM in a separate tube. Both solutions were mixed and incubated at
RT for 30min. During the incubation time, themediumof the cells was changed
to 5 ml OptiMEM per dish. Finally, 3 ml transfection mix was added to each
dish. After 7–8 hr, themediumwas replaced by 9ml OptiMEMper dish, without
addition of FBS. The virus-containing medium was harvested 40–45 hr after
medium change, cleared by centrifugation at 2500 3 g for 10 min at 4C,
and filtered through 0.45 mm filter units (Millipore). Virus concentration was
carried out by ultracentrifugation in a Beckman Optima L-90K ultracentrifuge
using a SW32 Ti rotor at 50,000 3 g for 3 hr with a purification layer of 1 ml
20% sucrose (in dH20) added to the bottom of the centrifuge tubes. Subse-
quently, the virus was resuspended in 50–100 ml 13 PBS, aliquoted, and
stored at70C. The titer of concentrated lentivirus was determined by trans-
ducing 1 3 105 HEK293T cells per well in a 24-well cell-culture plate with
limiting virus dilutions and quantification of GFP-positive cells by FACS
analysis after 3 days. Titers of concentrated lentivirus were in the range of
5 3 108 – 2 3 109 TU ml–1.
Stereotaxic Injections
Tabac mice, aged 8–13 weeks, were anesthetized with ketamine and xylazine
(130 and 10 mg kg–1) and placed in a Benchmark stereotaxic frame with a
Cunningham mouse adaptor. One-half microliters of virus was injected
bilaterally with a pulled glass pipette (flow rate 0.1 ml min–1) into the MHb at
the following coordinates: antero-posterior (from bregma): –1.4 mm and
–1.75 mm; lateral: ± 0.36 mm; and dorso-ventral (from skull level): –2.7 mm
and –2.72 mm. Behavioral experiments started 2 weeks after injections. Veri-
fication of the injection sites was done on brain sections immunostained with
rabbit polyclonal anti-RFP (Molecular Probes) diluted 1:1000.Neuron 70, 522–535, May 12, 2011 ª2011 Elsevier Inc. 533
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Unpaired two-tailed Student’s t tests were used for analyzing most of the data,
except when two-way analysis of variance (ANOVA) or paired two-tailed
Student’s t tests are indicated. Results are presented as means ± SEM.SUPPLEMENTAL INFORMATION
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